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Background. The intracellular domain (ICD) of the neurotrophin receptor, p75NTR, exhibits variably pro- and antiapoptotic
activity and has been implicated in neurodegenerative and neurodestructive disease. The molecular determinants of these cellular
eﬀects are not completely understood. The “Chopper” domain of p75ICD has been shown to be proapoptotic in in vitro systems
in which p75ICD is proapoptotic. The eﬀects of Chopper in systems in which p75ICD is antiapoptotic and, therefore, whether
or not Chopper accounts for the variability of the cellular eﬀects of p75ICD are not known. We therefore examined the eﬀects of
deletionofChopperontheeﬀectsofp75ICDoninvitrocellculturesystemsinwhichp75ICDispro-orantiapoptotic,respectively.
Results. In HN33.11 murine neuroblastoma-hippocampal neuron hybrid cells, p75ICD is antiapoptotic. In NIH 3T3 cells, p75ICD
is proapoptotic. In both cell lines deletion of the Chopper domain from p75ICD decreases the incidence of apoptosis resulting
from oxidative stress. Thus, irrespective of the nature of the eﬀects of p75ICD on the cell, its Chopper domain is proapoptotic.
Conclusions. Expression of p75ICD can enhance or attenuate oxidative induction of apoptosis. Variability of the eﬀects of p75ICD
is not related to variability of the eﬀects of its Chopper domain.
1.Background
The neurotrophin receptor, p75NTR, has been implicated in
the pathogenesis of neurodegenerative and neurodestructive
diseases, including Alzheimer’s disease [1–3], Parkinson’s
disease [4], invasive glioblastoma [5], and chemoresistant
neuroblastoma[6].Itcanbepro-orantiapoptoticdepending
on the milieu in which it is expressed [6, 7]. Its activity ap-
pears to be mediated by its intracellular domain (p75ICD;
[8, 9]). p75ICD can substitute for full-length p75NTR in
both protective [8, 9] and death-inducing [7] models.
p75NTR is a member of the tumor necrosis factor family
of death receptors. As such, its C-terminal, CD95-like
death domain was originally assumed to be responsible for
its proapoptotic properties. However, the p75NTR death
domain does not behave like the death domains of other
tumor necrosis factor family death receptors [10–12]. The
Chopper region at the juxtamembrane end of p75ICD has
been shown to be both necessary and suﬃcient for apoptosis
induction by p75NTR. Chopper must be either membrane-
anchored or palmitoylated to function in this way; in fact,
when it is not, it is a dominant negative inﬂuence on this
activity in models in which p75NTR is proapoptotic [13].
We have characterized neural crest tumor models in
which p75ICD is either protective against oxidative stress
and, therefore, antiapoptotic [8, 9] or facilitatory of mitotic
arrest and, therefore, proapoptotic [7]. We now demonstrate
that, in both antiapoptotic and proapoptotic model systems,
p75ICD-bound Chopper appears to be proapoptotic. This
suggeststhatthevariablenatureoftheactivityofp75ICDvis-
` a-vis cell survival is not the result of variability of Chopper
function.2 Oxidative Medicine and Cellular Longevity
2. Methods
2.1. Genetic Constructs and Cell Culture Models. The
HN33.11line(giftfromBruceWainer,EmoryUniversity,At-
lanta, GA) is a hybrid line of murine neuroblastoma and
primary hippocampal neurons. These cells have been used
as an immortalized model for the study of disorders of the
hippocampus [14], one of the few brain regions in which
p75NTR is expressed in the adult [15]. HN33.11 cells were
cultured in Dulbecco’s Minimal Essential Medium (DMEM)
supplemented with 8% fetal bovine serum (Atlanta Bio-
logicals, Norcross, GA).
Full-length p75ICD (A) and Chopper-deleted p75ICD
(B) constructs were cloned with a V5 epitope into the
pBig2i-MCS-GFP doxycycline- (Dox-; Sigma-Aldrich, St.
Louis, MO) regulated vector (Invitrogen, Carlsbad, CA;
Figure 1). Plasmids were transfected into HN33.11 cells
using Lipofectamine 2000 (Invitrogen) and stable lines were
selected for resistance to Hygromycin (400mg/mL; Invit-
rogen). Construct inducibility was veriﬁed by ﬂuorescence
microscopy for GFP expression and Western blot analysis
for p75ICD fragment expression after Dox exposure for 36–
48 hours. Individual GFP-positive and GFP-negative clones
were isolated for study.
NIH 3T3 cells (American Type Culture Collection, Rock-
ville,MD)werealsostudiedtodeterminetheeﬀectsoftrans-
fection with an expression construct for (A) or (B), as, unlike
HN33.11 cells, they do not express endogenous p75NTR (Mi
and Schor, unpublished results; also see Figure 8, mcs lane).
Transfection, selection, and clonal isolation of NIH 3T3 cells
were performed as described above for HN33.11 cells.
2.2. Western Blots. Protein concentrations were determined
using the Bradford assay (Bio-Rad Protein Assay, Bio-Rad
Laboratories, Hercules, CA), and 15μgo fp r o t e i nw a sl o a d e d
onto a 15% sodium dodecyl sulfate-polyacrylamide gel and
transferred to a polyvinylidine ﬂuoride membrane (Milli-
pore, Bedford, MA) as we have described previously [16].
Western blot analysis was performed using anti-p75ICD
(Promega, Fitchburg, WI; 1:1000) and anti-V5 (Novus,
Littleton, CO; 1:4000) antibodies.
2.3. Exposure to Oxidant Stress. Cells were treated with 6-
hydroxydopamine (6-OHDA; Sigma-Aldrich) or H2O2 in
complete (i.e., serum-containing) culture medium for 1
hour. Media were replaced and cells were incubated for 48
hours before analysis via ﬂow cytometry or the MTS viability
assay (see what follows).
2.4. Cell Cycle Analysis. 2 × 106 cells were ﬁxed in ethanol,
treated with RNase, and stained with propidium iodide to
detect DNA. GFP-expressing and -nonexpressing cells were
analyzed as we have previously described [6] in the presence
and absence of Dox.
2.5.MTSAssay. 20μLofCellTiter96AQueousOneSolution
R e a g e n t( P r o m e g a )w a sa d d e di n t oe a c hw e l lo ft h e9 6 -
well assay plate containing the samples in 100μLo fc u l t u r e
medium. The plate was incubated at 37◦Cf o r1h o u ri na
humidiﬁed, 5% CO2 atmosphere before reading the optical
density of each well at 490nm (OD490nm)i nap l a t er e a d e r .
2.6. Determination of Caspase-3 Cleavage by Western Blot.
Cells were harvested at 0, 6, 9, 12, and 24 hours after 6-
OHDA or vehicle treatment. Cell pellets were resuspended
into radioimmunoprecipitation assay buﬀer (10mM Tris,
pH 8; 150mM NaCl; 0.1% Nonidet P-40; 0.5% sodium de-
oxycholate; 0.1% SDS; 1mM phenylmethylsulfonyl ﬂuoride;
4μg/mL aprotinin; and 1mM sodium orthovanadate; all
from Sigma-Aldrich) and, after sonication and centrifuga-
tion,aliquotsofsupernatantscontainingequivalentamounts
of protein were loaded onto a sodium dodecyl sulfate-
polyacrylamide gel for Western blotting. Blots were stained
with a primary rabbit antibody against cleaved caspase-3
and a goat-anti-rabbit secondary antibody (Cell Signaling
Technology, Beverly, MA).
2.7. Hoechst Dye Assay for Apoptosis. After treatment with 6-
OHDA, cells were washed once with Dulbecco’s phosphate-
buﬀered saline and ﬁxed with cold 95% ethanol. Hoechst
dye 33342 (Sigma-Aldrich; 2mg/mL stock solution) was
then added into the cells in a 1:200 dilution in Dulbecco’s
phosphate-buﬀered saline; the cells were then incubated for
30 minutes at room temperature. Cells were washed once in
Dulbecco’s phosphate-buﬀered saline and mounted on slides
for ﬂuorescence microscopic analysis.
2.8. Statistical Analysis. Between-group comparisons for
parametric variables were performed using Student’s t-test.
DiﬀerenceswereconsideredstatisticallysigniﬁcantattheP ≤
0.05 level.
3. Results
3.1. Analysis of the Dox-Regulated p75ICD Vector System in
HN33.11 Cells. HN33.11 cells transfected with either the
control GFP vector, C2eGFP, or the test plasmid, MCSires-
GFP, were treated with Dox (0.5–3μg/mL). Dox induced
GFPexpressioninMCSiresGFP-transfectedcells.Incontrast,
Dox treatment did not enhance GFP expression in C2eGFP-
transfected cells (Figure 2(a)).
HN33.11 cells were then transfected with either the
MCSiresGFP, (A)-GFP, or (B)-GFP expression construct.
Dox induced GFP expression in all cases, although the (A)
and (B) constructs exhibited some degree of “leakiness” in
the absence of Dox (Figure 2(b)).
Stable lines were created from two clones each of
(A)-GFP-transfected and (B)-GFP-transfected cells. Dox-
induced GFP expression was demonstrated in all cases
(Figure 3(a)) and GFP-positive and GFP-negative clones
were isolated. Figure 3(b) demonstrates, however, that these
HN33.11-derived clones also express endogenous full-length
p75NTR at approximately the same level for all of the
clones, making the induced p75ICD (A) and (B) a presumed
increment to the p75ICD that could be generated through
endogenous cleavage of p75NTR.Oxidative Medicine and Cellular Longevity 3
bGH pA rtTA TK tetO CMV bGH pA IRES GFP p75 ICD
KRWNSCKQNKQGANSRPVNQTPPPEGEKLHSDSGISVDSQSLHDQQTHTQTASGQALKGDGNLYSSLPLTKREEVEKLLNGDTWRHLAGELGYQPEHIDSFTHEACPVRALLASWGAQDSATLDALLAALRRIQRADIVESLCSESTATSPV*
Chopper Domain    PDZ  Death Domain
PEST  Traf 2 Binding Domain
274
V5-STOP
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Figure 1: Regulating p75ICD expression using the pBIG2i Tet-inducible expression system. Full-length p75ICD (ICD-A) or the N-terminal
deletion mutant (ICD-B) was expressed from the bidirectional tetracycline regulated vector pBIG2i. In the presence of ligand (doxycycline),
the reverse transactivator (rtTA) expressed from the thymidine kinase promoter (TK) binds to the heptemerized tetO sequence activating
transgene expression from both the minimal TK and CMV promoters. Inclusion of the IRES-eGFP cassette facilitates the analysis of p75ICD
expressing clones. Domains included in the full-length ICD include the amino terminal “chopper domain”, tandem PEST sequence, Traf2-
and PDZ-binding domains, and the carboxyl terminal death domain. In addition to using IRES-mediated GFP expression, both ICD
expression constructs contain the V5 epitope to monitor inducible ICD transgene expression.
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Figure 2: (a) Results of transfection of HN33.11 cells with green ﬂuorescent protein- (GFP-) linked empty plasmid (C2eGFP) or GFP-linked
multiple cloning site in the same plasmid with a doxycycline- (Dox-) inducible internal ribosome entry site (MCSiresGFP). Dox elicits
production of GFP in the MCSiresGFP-transfected cells, but not in C2eGFP-transfected cells. (b) Dox-inducibility of MCSiresGFP-linked
expression constructs for (A) and (B) as deﬁned in Figure 1. Open bars: cells maintained in the absence of Dox; closed bars: cells maintained
in the presence of Dox (1μg/mL). Results shown are the mean ± SEM of three independent experiments performed. ∗∗∗P<0.001; ∗∗P<
0.01 relative to absence of Dox, Student’s t-test.
3.2. Protective Eﬀects of (A)-GFP Expression in HN33.11 Cells.
Our previous studies demonstrated the protective eﬀects
of transfection with a p75ICD expression construct against
oxidative stress in p75NTR-negative PC12 pheochromo-
cytoma cells [8, 9]. Given that transfection of HN33.11
cells with (A)-GFP puts p75ICD into cells that are already
p75NTR-positive, we sought ﬁrst to test the hypothesis
that (A)-GFP expression would enhance the resistance of
HN33.11 cells to oxidant stress. As HN33.11 cells are known
to express a dopamine uptake system [17], we used 6-
OHDA to inﬂict oxidative stress, as we have in our previous
publication [8].
Figure 4(a) shows the concentration-cell survival curve
of HN33.11 cells to 6-OHDA. The stable lines indicated were
plated at 5 × 105 cells per 60mm dish and exposed to 6-
OHDA (300μM )f o r1h o u ra n di n c u b a t e df o r4 8h o u r s
prior to analysis by ﬂow cytometric quantitation of sub-
G1 (i.e., apoptotic) nuclei. Dox-induced expression of (A)-
GFP in HN33.11 cells (clones A37 and A38) is antiapoptotic
(Figure 4(b)).
To ensure that transfection alone with construct (A) or
construct (B) with or without GFP did not alter progression
of HN33.11 cells through the cell cycle, we examined the
transfectants by ﬂow cytometry in the absence of 6-OHDA.4 Oxidative Medicine and Cellular Longevity
Dox (−) Dox (+)
A37
A38
B2
B51
(a)
Dox
A37 A38 B2 B41 B51
FLp75
ICD
V5 tag
−−− − − ++++ +
(b)
Figure 3: (a) Light and ﬂuorescent micrographs of stable HN33.11
cells expressing (A)-GFP or (B)-GFP, respectively. Results from two
stable clones of each transfection pool are shown. Cells are treated
with vehicle (Dox−)o r1μg/mL Dox (Dox+). (b) Western blot of
homogenates of stable clones showing endogenous production of
full-length p75NTR (FLp75), Dox-induced, but “leaky” production
of (A) and (B) and of the V5 tag. Control values for each clone do
notdiﬀersigniﬁcantlybetweenGFP(−)andGFP(+)cells(Student’s
t-test). ∗∗∗P<0.001 relative to GFP(−)c e l l s .
ThedatashowninTable 1 indicatethatneitherconstruct(A)
nor construct (B) in the native or GFP-linked state alters the
cell cycle distribution of HN33.11 cells.
3.3. Eﬀects of Removal of the Chopper Domain from (A)-GFP
on Protection from Oxidative Stress in HN33.11 Cells. Ex-
pression construct (B)-GFP produces a GFP-linked protein
that represents p75ICD minus the Chopper domain. Two
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Figure 4: (a) Concentration-survival curve of HN33.11 cells to
6-hydroxydopamine (6-OHDA). Cell survival was determined by
MTS assay as described in Methods. (b) Eﬀects of Dox-induced
expression of (A)-GFP on induction cell death by 6-OHDA in
HN33.11 cells (clones A37 and A38). The stable lines indicated
were plated at 5×105 cells per 60mm dish and exposed to 6-OHDA
(300μM) for 1 hour and incubated for 48 hours prior to analysis by
ﬂow cytometric quantitation of sub-G1 nuclei. The results of one
experiment of three performed are shown.
clones (B2 and B51), both stable transfectants, of (B)-GFP-
transfected HN33.11 cells were used to test the eﬀects of
deletion of Chopper on the protective eﬀects of (A)-GFP
(clones A37 and A38).
Results for clones A37 and A38 were comparable, as were
results for clones B2 and B51. Data are therefore shown
for clones A37 and B2. Figure 5 compares the time course
for detection of activated caspase-3 after a 1 hour exposure
to 6-OHDA (150μM) in MCS-GFP-transfected (control)Oxidative Medicine and Cellular Longevity 5
Table 1: Baseline inﬂuence of p75ICD fragment expression on cell
cycle.
Construct A Construct B
eGFP− eGFP+ eGFP− eGFP+
Sub-G1 1.9 2.3 3.8 6.6
G1 66.6 41.2 62.5 50.0
S 18.6 28.2 19.3 22.1
G2 11.5 26.6 12.9 18.9
cells and clones A37 and B2. As expected, transfection
with (A)-GFP protects HN33.11 from 6-OHDA-induced
activation of caspase-3 and attenuates the time course of
such activation. Transfection with (B)-GFP makes this eﬀect
more pronounced; that is, deletion of the Chopper domain
further protects the cells from 6-OHDA and attenuates the
time course of caspase-3 activation.
Morphological studies (Figure 6) document the atten-
uation of apoptosis induction by 6-OHDA (150μMf o r1
hour; photos taken 24 hours after completion of 6-OHDA
treatment) in clone A37 relative to stable MCS-GFP cells and
i nc l o n eB 2r e l a t i v et oc l o n eA 3 7 .
Flow cytometric analysis of the prevalence of sub-G1
nuclei cells of clone B2 treated with 6-OHDA (300μM) is
shown in Figure 7. Comparison of these results with those
shown for the (A)-GFP clones in Figure 4(b) demonstrates
that removal of the Chopper domain from the (A)-GFP
construct does not block the protection of HN33.11 cells
from oxidative stress.
3.4. Analysis of the Dox-Regulated p75ICD Vector System in
NIH 3T3 Cells. In an eﬀort to study the eﬀects of trans-
fection with (A)-GFP and (B)-GFP on cells that do not
endogenously express p75NTR or p75ICD, we made stable
transfectants of NIH 3T3 cells with these constructs and
with MCS-GFP (control). Because NIH 3T3 cells do not
express a catecholamine transporter [18], we subjected them
to oxidative stress using H2O2. Our previous studies had
demonstrated the qualitative equivalency of 6-OHDA and
H2O2 as generators of oxidative stress in other cellular
models of p75NTR-mediated modulation of susceptibility to
reactive oxygen species [8].
Figure 8 demonstrates that NIH 3T3 cells transfected
with MCS do not express p75ICD; transfection with con-
struct (A) or construct (B), respectively, results in expression
of each of the two fragments of p75ICD. In this context,
the expression construct is suﬃciently “leaky” as to preclude
turning expression on and oﬀ using Dox. Eﬀects of oxidative
stress on NIH 3T3 transfectants are therefore the same in the
presence and absence of Dox (data not shown).
3.5. Eﬀects of Expression of Construct (A) or Construct (B)
on Cell Death Induced by Oxidative Stress in NIH 3T3 Cells.
In contrast to the protective eﬀects of construct (A) in
HN33.11, construct (A) potentiates cell death induced by
treatment with H2O2 in NIH 3T3 cells (Figure 9). Deletion
of the Chopper domain and transfection with the resultant
construct (B) returns the response of NIH 3T3 cells to
oxidative stress to that of the MCS-transfected cells; that
is, deletion of the Chopper domain protects NIH 3T3 cells
from the eﬀects of transfection with p75ICD. This suggests
that, although p75ICD expression has opposite eﬀects on
sensitivity to oxidative stress in HN33.11 and NIH 3T3
cells, respectively, the Chopper domain is proapoptotic
in both cell lines and the diﬀerential eﬀects of p75ICD
(i.e., construct (A)) are not related to diﬀerential signaling
through Chopper.
4. Discussion
The neurotrophin receptor, p75NTR, functions both as a
low aﬃnity, independent receptor and as a coreceptor with
TrkA. In its independent function, it serves as an initiator
of both pro- and antiapoptotic signaling pathways. It is one
of a growing family of “dependence receptors”—receptors
that confer cellular dependence on growth factors for life-or-
death decision-making [19].
The binding of nerve growth factor to the extracellular
domain of p75NTR and the subsequent binding of a variety
of interactor proteins with its intracellular domain result in
the sequential cleavage of p75NTR by α-a n dγ-secretase to
liberate the intracellular domain of p75NTR, p75ICD [20].
We have previously demonstrated that p75ICD is suﬃcient
for the variably pro- and antiapoptotic activities of p75NTR
in some in vitro systems [8, 9]. An N-terminal segment of
p75ICD has been termed “Chopper” and has been shown
to be proapoptotic in an in vitro system in which holo-
p75NTR is proapoptotic [13]. In the present study, we asked
the question of whether Chopper would, conversely, be
antiapoptotic in an in vitro system in which holo-p75NTR is
antiapoptotic. That is, we tested the hypothesis that Chopper
activitydetermineswhetherp75NTRispro-orantiapoptotic
in a given system.
The results we present are not consistent with this
hypothesis. They demonstrate that Chopper is proapoptotic
whetherholo-p75NTR ispro-orantiapoptotic. Thevariabil-
ity of the eﬀects of p75NTR on cell survival is therefore not
related to variability of the eﬀects of Chopper.
While the tyrosine kinase receptors have long been
known to modulate such processes as cell death, pro-
liferation, protection, and diﬀerentiation in development
and disease of the nervous system (reviewed in [21]), the
involvement of p75NTR in development and disease is much
less well characterized (reviewed in [22]). However, recent
studies make it likely that p75NTR plays diﬀerent roles in
Alzheimer’s disease [1–3], Parkinson’s disease [4], diﬀeren-
tiation and synaptic connectivity along the neuraxis [23],
resistance of neural tumors to chemotherapy [6], and migra-
tion of glioblastoma cells away from the primary tumor [5].
Expression of p75NTR in the central nervous system is
developmentally restricted such that, as humans progress
from embryonic life to adulthood, p75NTR goes from ubiq-
uitous expression to expression largely limited to cholinergic
neurons in the basal forebrain and hippocampus (reviewed
in[22]).Inaddition,p75NTRandamyloidprecursorprotein6 Oxidative Medicine and Cellular Longevity
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Figure 5: Time course of activation of caspase-3 after treatment with 6-OHDA (150μM, 1 hour exposure) in stable MCS, A37, and B2
clones. Activated caspase-3 levels were determined by Western blotting and optical densitometry of the resulting bands. Protection from
caspase-3 activation is greatest in B2 cells and less robust in A37 cells.
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Figure 6: Hoechst dye staining of MCS, A37, and B2 cells 48 hours
after treatment with 6-OHDA (150μM, 1 hour exposure). Two-
hundred total cells were counted in each treated well to determine
the percent of the cells that exhibited nuclear condensation and/or
fragmentation and margination of DNA. P values for A37 and
B2 cells are calculated by Student’s t-test relative to MCS cells.
Protection from morphologic apoptosis is greatest in B2 cells and
less robust in A37 cells.
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Figure 7: Stable (B)-GFP transfectants were treated with vehicle
or 6-OHDA in the absence or presence of Dox and studied by
ﬂow cytometry as for (A)-GFP transfectants shown in Figure 4.T h e
results of one experiment of two performed are shown. Control
values are not siginiﬁcantly diﬀerent (Student’s t-test) between
GFP(−) and GFP(+) cells. ∗P = 0.05 relative to GFP(−)c e l l s .
(APP) have been shown to interact and, in their interaction,
to induce neuronal death. p75NTR inﬂuences processing of
APP and both NGF and β-amyloid alter the p75NTR-APP
interaction [24]. Furthermore, p75NTR is a substrate for
presenilin-1 and the two are coregulated in model systems
and during normal development [1, 2]. These observationsOxidative Medicine and Cellular Longevity 7
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Figure 8: Induction by Dox is shown for GFP in all cell lines, for
(A)-GFP in the a1 clone, and for (B)-GFP in the b1 clone of NIH
3T3 cells by Western blotting as described in Methods. Note that
some (A)-GFP and (B)-GFP are produced in a1 and b1 clones,
respectively, in the absence of Dox.
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Figure 9: p75ICD ((A)-GFP; a1 clone) potentiates induction of
cell death (MTS assay) by H2O2 in NIH 3T3 cells. Deletion of the
Chopper domain from p75ICD ((B)-GFP; b1 clone) restores the
resistanceofthesecellstoH2O2.Resultsshownarethemean ±SEM
of three independent experiments performed.
have implicated p75NTR in the pathogenesis of Alzheimer’s
disease.
The proNGF-sortillin-p75NTR complex has been impli-
cated in apoptosis associated with Parkinson’s disease. This
complex has been suggested as a potential target in the pre-
vention of degeneration of neurons in the substantia nigra
[4].
Pruning of axons during developmental neurite out-
growth has recently been shown to be a p75NTR-dependent
process [25]. Brain-derived neurotrophic factor (BDNF)
is the cognate p75NTR ligand that orchestrates activity-
dependent persistence of axons during development. Those
axons that are less active degenerate in a process that requires
p75NTR.
Resistance of PC12 pheochromocytoma cells to chem-
otherapy [6], potentiation of neuroblastoma cell death after
oxidative chemotherapy [26], and migration away from the
primary tumor with central nervous system invasiveness of
glioblastomas [5] all depend critically on p75NTR.
Understanding the structural and molecular underpin-
nings of p75NTR function and its context dependence may
therefore identify novel targets for the treatment or pre-
vention of neurodegenerative disease, developmental aber-
rations of the nervous system, and nervous system cancer.
Molecular “dissection” of p75ICD may facilitate functional
segregation of its pro- and antiapoptotic eﬀects and facilitate
manipulation of one or the other of the signaling cascades
triggered by p75NTR and involved in speciﬁc pathologic or
developmental processes. The results of the present study
raise the question of whether Chopper-free fragments of
p75NTR or p75ICD might be prototypes for antioxidant and
antiapoptotic therapeutic strategies in the nervous system.
5. Conclusions
The cellular function of p75NTR is cell- and context-
dependent. In contrast, the cellular function of Chopper is
not dependent on the function of p75NTR within a par-
ticular cell or context. Chopper is proapoptotic in cells in
whichp75NTRiseitherpro-orantiapoptotic.Thevariability
of function of p75NTR is, therefore, not a result of variable
function of Chopper. Furthermore, Chopper-free fragments
of p75NTR or p75ICD may be viable prototypes for the
development of antiapoptotic strategies for the treatment of
neurodegenerative disease.
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